Loss and gain of ceftazidime-avibactam susceptibility in a non-carbapenemase-producing K1-ST23 hypervirulent Klebsiella pneumoniae

被引:0
|
作者
Zhao, Jiankang [1 ,2 ,3 ,4 ,5 ]
Pu, Danni [1 ,2 ,3 ,4 ,5 ,6 ]
Li, Ziyao [1 ,2 ,3 ,4 ,5 ]
Zhang, Yulin [1 ,2 ,3 ,4 ,5 ]
Liu, Xinmeng [1 ,2 ,3 ,4 ,5 ]
Zhuo, Xianxia [1 ,2 ,3 ,4 ,5 ,7 ]
Lu, Binghuai [1 ,2 ,3 ,4 ,5 ,6 ]
Cao, Bin [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构
[1] Natl Ctr Resp Med, Beijing, Peoples R China
[2] State Key Lab Resp Hlth & Multimorbid, Beijing, Peoples R China
[3] Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China
[5] China Japan Friendship Hosp, Ctr Resp Med, Beijing, Peoples R China
[6] Chinese Acad Med Sci, Beijing, Peoples R China
[7] Capital Med Univ, Beijing, Peoples R China
[8] Tsinghua Univ Peaking Univ Joint Ctr Life Sci, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Hypervirulent Klebsiella pneumoniae; ceftazidime-avibactam resistance; CTX-M-71; OmpK36; non-carbapenemase-producing strain; BETA-LACTAMASE; OUTER-MEMBRANE; CLINICAL ISOLATE; ENTEROBACTERIACEAE; RESISTANCE; EMERGENCE; SEQUENCE;
D O I
10.1080/21505594.2024.2348251
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives This study aimed at revealing the underlying mechanisms of the loss and gain of ceftazidime-avibactam susceptibility in a non-carbapenemase-producing hypervirulent Klebsiella pneumoniae (hvKp). Methods Here we longitudinally recovered 3 non-carbapenemase-producing K1-ST23 hvKp strains at a one-month interval (KP29105, KP29499 and KP30086) from an elderly male. Antimicrobial susceptibility testing, whole genome sequencing, transcriptomic sequencing, gene cloning, plasmid conjugation, quantitative real-time PCR (qRT-PCR), and SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) were conducted. Results Among the 3 hvKp strains, KP29105 was resistant to the third- and fourth-generation cephalosporins, KP29499 acquired resistance to both ceftazidime-avibactam and carbapenems, while KP30086 restored its susceptibility to ceftazidime-avibactam, imipenem and meropenem but retained low-level resistance to ertapenem. KP29105 and KP29499 carried plasmid-encoded genes bla(CTX-M-15) and bla(CTX-M-71), respectively, but KP30086 lost both. Cloning of gene bla(CTX-M-71) and conjugation experiment of bla(CTX-M-71)-carrying plasmid showed that the transformant and transconjugant were susceptible to ceftazidime-avibactam but had a more than 8-fold increase in MICs. Supplementation with an outer membrane permeabilizer could reduce the MIC of ceftazidime-avibactam by 32 folds, indicating that porins play a key role in ceftazidime-avibactam resistance. The OmpK35 of the 3 isolates was not expressed, and the OmpK36 of KP29499 and KP30086 had a novel amino acid substitution (L359R). SDS-PAGE and qRT-PCR showed that the expression of porin OmpK36 of KP29499 and KP30086 was significantly down-regulated compared with KP29105. Conclusions In summary, we reported the rare ceftazidime-avibactam resistance in a non-carbapenemase-producing hvKp strain. Resistance plasmid carrying blaCTX-M-71 and mutated OmpK36 had a synergetic effect on the resistance.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae
    Wenxia Zhang
    Yan Guo
    Jiayin Li
    Yiyuan Zhang
    Yang Yang
    Dong Dong
    Demei Zhu
    Ping He
    Fupin Hu
    [J]. Antimicrobial Resistance & Infection Control, 7
  • [2] Epidemiology of resistance of carbapenemase-producing Klebsiella pneumoniae to ceftazidime-avibactam in a Chinese hospital
    Chen, D.
    Xiao, L.
    Hong, D.
    Zhao, Y.
    Hu, X.
    Shi, S.
    Chen, F.
    [J]. JOURNAL OF APPLIED MICROBIOLOGY, 2022, 132 (01) : 237 - 243
  • [3] Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature
    Shields, Ryan K.
    Hong Nguyen, M.
    Press, Ellen G.
    Chen, Liang
    Kreiswirth, Barry N.
    Clancy, Cornelius J.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (03): : 1 - 4
  • [4] Ceftazidime-avibactam based combinations against carbapenemase producing Klebsiella pneumoniae harboring hypervirulence plasmids
    Bulman, Zackery P.
    Tan, Xing
    Chu, Ting-Yu
    Huang, Yanqin
    Rana, Amisha P.
    Singh, Nidhi
    Flowers, Stephanie A.
    Kyono, Yasuhiro
    Kreiswirth, Barry N.
    Chen, Liang
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 (3946-3954): : 3946 - 3954
  • [5] In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae
    Zhang, Wenxia
    Guo, Yan
    Li, Jiayin
    Zhang, Yiyuan
    Yang, Yang
    Dong, Dong
    Zhu, Demei
    He, Ping
    Hu, Fupin
    [J]. ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2018, 7
  • [6] Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study
    Tumbarello, Mario
    Raffaelli, Francesca
    Giannella, Maddalena
    Mantengoli, Elisabetta
    Mularoni, Alessandra
    Venditti, Mario
    De Rosa, Francesco Giuseppe
    Sarmati, Loredana
    Bassetti, Matteo
    Brindicci, Gaetano
    Rossi, Marianna
    Luzzati, Roberto
    Grossi, Paolo Antonio
    Corona, Alberto
    Capone, Alessandro
    Falcone, Marco
    Mussini, Cristina
    Trecarichi, Enrico Maria
    Cascio, Antonio
    Guffanti, Elena
    Russo, Alessandro
    De Pascale, Gennaro
    Tascini, Carlo
    Gentile, Ivan
    Losito, Angela Raffaella
    Bussini, Linda
    Corti, Giampaolo
    Ceccarelli, Giancarlo
    Corcione, Silvia
    Compagno, Mirko
    Giacobbe, Daniele Roberto
    Saracino, Annalisa
    Fantoni, Massimo
    Antinori, Spinello
    Peghin, Maddalena
    Bonfanti, Paolo
    Oliva, Alessandra
    De Gasperi, Andrea
    Tiseo, Giusy
    Rovelli, Cristina
    Meschiari, Marianna
    Shbaklo, Nour
    Spanu, Teresa
    Cauda, Roberto
    Viale, Pierluigi
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : 1664 - 1676
  • [7] Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K-pneumoniae
    Tumbarello, Mario
    Trecarichi, Enrico Maria
    Corona, Alberto
    De Rosa, Francesco Giuseppe
    Bassetti, Matteo
    Mussini, Cristina
    Menichetti, Francesco
    Viscoli, Claudio
    Campoli, Caterina
    Venditti, Mario
    De Gasperi, Andrea
    Mularoni, Alessandra
    Tascini, Carlo
    Parruti, Giustino
    Pallotto, Carlo
    Sica, Simona
    Concia, Ercole
    Cultrera, Rosario
    De Pascale, Gennaro
    Capone, Alessandro
    Antinori, Spinello
    Corcione, Silvia
    Righi, Elda
    Losito, Angela Raffaella
    Digaetano, Margherita
    Amadori, Francesco
    Giacobbe, Daniele Roberto
    Ceccarelli, Giancarlo
    Mazza, Ernestina
    Raffaelli, Francesca
    Spanu, Teresa
    Cauda, Roberto
    Viale, Pierluigi
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 68 (03) : 355 - 364
  • [8] Patient-to-Patient Transmission of Klebsiella pneumoniae Carbapenemase Variants with Reduced Ceftazidime-Avibactam Susceptibility
    Munoz-Price, L. Silvia
    Reeme, Allison E.
    Buchan, Blake W.
    Mettus, Roberta T.
    Mustapha, Mustapha M.
    Van Tyne, Daria
    Shields, Ryan K.
    Doi, Yohei
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (10)
  • [9] Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae
    Davido, Benjamin
    Cremieux, Anne-Claude
    Vaugier, Isabelle
    Gatin, Laure
    Noussair, Latifa
    Massias, Laurent
    Laurent, Frederic
    Saleh-Mghir, Azzam
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 61 (01)
  • [10] Ceftazidime-avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae
    Lima, O.
    Sousa, A.
    Longueira-Suarez, R.
    Filgueira, A.
    Taboada-Martinez, C.
    Portela-Pino, C.
    Nodar, A.
    Vasallo-Vidal, F.
    Martinez-Lamas, L.
    Perez-Landeiro, A.
    Rubianes, M.
    Perez-Rodriguez, M. T.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (09) : 1173 - 1182